Ehret, F.; Abid, F. B.; Ribeiro, V. T.; Bodden, R.; Maluf, F. C.; Larco-Castilla, P.; Naud, L. M.; Ferraz de Paula Soares, C.; Shaikh, E.; Valente de Camargo, L.; Ridolfi, F. M. The IDEAL Trial - a Study Protocol for a Phase III Randomized, Double-Blinded Clinical Trial Assessing the Ultra-Short Antibiotic Prophylaxis of Isoniazid and Rifapentine in Non-Immunosuppressed Patients With Newly Diagnosed Latent Tuberculosis. PPCR 2020, 6, 9-14.